Pasar al contenido principal

METABOLISMO DE POLIFENOLES Y NUTRICION PERSONALIZADA EN LA MENOPAUSIA: METABOTIPOS, MICROBIOMA-VIROMA Y RELACION CON CALIDAD DE VIDA Y RIESGO CARDIOVASCULAR

PID2022-136419OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

(R,S)-Equol 7-β-D-glucuronide, but not other circulating isoflavone metabolites, modulates migration and tubulogenesis in human aortic endothelial cells targeting the VEGF pathway

  • Giménez-Bastida, J. A.
  • Ávila-Gálvez, María Ángeles
  • Martínez-López, Alicia
  • García-Moreno, Diana
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
Current knowledge indicates that the consumption of isoflavone-rich foodstuffs can have a beneficial impact on cardiovascular health. To what extent these isoflavones act as the main actors of that benefit is less clear. Genistein (GEN), daidzein (DAZ), and the DAZ-derived microbial metabolite equol (Eq) exhibit antiangiogenic effects in vitro, but their low bloodstream concentrations make it difficult to rationalize the in vivo effects. Their derived phase-II metabolites (glucuronides and sulfates) are major metabolites found in plasma, but their role as antiangiogenic molecules remains unexplored. We aimed here to first assess the anti-angiogenic activities of the main circulating isoflavone metabolites (glucuronides and sulfates) and compare them with their corresponding free forms at physiological concentrations (0.1–10 μM). The effects of the conjugated vs. free forms on tubulogenesis, cell migration, and VEGF-induced signalling were investigated in primary human aortic endothelial cells (HAECs). While (R,S)-equol 7-β-D-glucuronide (Eq 7-glur) exerted dose-dependent inhibition of tubulogenesis and endothelial migration comparable to that exerted by the free forms (GEN, DAZ, and Eq), the rest of the phase-II conjugates exhibited no significant effects. The underlying molecular mechanisms were independent of the bFGF but related to the modulation of the VEGF pathway. Besides, the observed dissimilar cellular metabolism (conjugation/deconjugation) places the phase-II metabolites as precursors of the free forms; however, the question of whether this metabolism impacts their biological activity requires additional studies. These new insights suggest that isoflavones and their circulating metabolites, including Eq 7-glur, may be involved in cardiovascular health (e.g., targeting angiogenesis), J. A. G.-B. was supported by a Standard European Marie Curie Individual Fellowship from the European Commission. D. G.-M. was supported by a Miguel Servet contract (AES 2021; CP21/00028) funded by the Institute Carlos III and by “ERDF a way of making Europe”. This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 838991. This work was supported by the Ramón y Cajal grant (RyC2021-032111-I) and by the grants CNS2022-135253 and TED2021-130962B-C22 funded by the MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” program, grants PID2022-136915NA-I00 and PID2022-136419OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” by the European Union, and the grant 22030/PI/22 funded by the Programa Regional de Fomento de la Investigación Científica y Técnica (Plan de Actuación 2022) de la Fundación Séneca-Agencia de Ciencia y Tecnología de la Región de Murcia, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals

  • Cortés-Martín, Adrián
  • Iglesias-Aguirre, Carlos E.
  • Marín Fernández, Alicia
  • Romo Vaquero, María
  • Vallejo, Fernando
  • Espín de Gea, Juan Carlos
  • Selma, María Victoria
The metabolism of (poly)phenols and some host metabolites, including bile acids (BAs) and cholesterol, varies among individuals depending on their gut microbiota. The gut microbial metabolism of ellagitannins (ETs) and ellagic acid (EA) produces urolithins (Uros), yielding three metabotypes with quantitative and qualitative differences based on dissimilar Uro-producing profiles (UM-A, UM-B, and UM-0, i.e., non-producers). Previous animal studies demonstrated that polyphenols impact BAs and cholesterol microbial metabolism, but data on their effects in humans and data regarding the inter-individual variability of these metabolic conversions are scant. We evaluated whether UMs, as distinctive functional gut-microbiome signatures, could determine the potential effect of a pomegranate extract (PE) rich in ET-EA on the metabolism of BAs and cholesterol in mild dyslipidaemic overweight-obese individuals, with possible consequences on host-lipid homeostasis and gut health. At the baseline, UM-B presented the highest levels of faecal total and secondary BAs and coprostanol, suggesting that the lipid absorption capacity and gut cytotoxic risk could be augmented in UM-B. PE intake significantly reduced faecal coprostanol and BA production, especially secondary BAs, and modulated the gut microbiome, reducing the gut cytotoxic risk, especially in UM-B individuals. The lowering of faecal microbial coprostanol and BAs and some BA-metabolising bacteria was quantitatively correlated with Uro concentrations, mainly faecal Uro-A. This suggests that PE consumption could exert cardiovascular and gut protection through Uro-A production as a direct driver of the effects and indirectly by reducing the Coriobacteriaceae family and BA pool, known factors involved in the gut absorption of lipids, This work has been funded by the Projects 20880/PI/18 (Fundación Séneca de la Región de Murcia, Spain), PID2022-136419OB-100 and AGROALNEXT programme by the Ministry of Science and Innovation (MICIN, AEI/10.13039/501100011033, and PRTR-C17.I1, Spain) with funding from “ERDF A way of making Europe”, the European Union NextGenerationEU (PRTR-C17.I1) and by Fundación Séneca with funding from Comunidad Autónoma Región de Murcia (CARM). C.E.I.-A. holds a predoctoral grant from MICIN (grant number FPU18/03961), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic Profiling of a Mediterranean-Inspired (Poly)phenol-Rich Mixture in the Brain: Perfusion Effect and In Vitro Blood-Brain Barrier Transport Validation

  • Ávila-Gálvez, María Ángeles
  • Garay-Mayol, Beatriz
  • Marín, Alicia
  • Brito, María Alexandra
  • Giménez-Bastida, J. A.
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
A Mediterranean diet rich in (poly)phenols has been linked to neuroprotection, but its effects likely depend on the ability of phenolic metabolites to cross the blood-brain barrier (BBB). This study evaluated the kinetics plasma and brain distribution of phenolic metabolites in Sprague-Dawley rats following oral administration of a polyphenol-rich extract mixture from Mediterranean foods (pomegranate, lemon, orange, grape, and olive). UPLC-ESI-QTOF analyses revealed 39 phenolic-derived metabolites in plasma, of which 20 were in nonperfused (NPB) and 19 in perfused brains (PB), including hydroxytyrosol and tyrosol sulfates, ellagic acid, dihydrocaffeic acid, and derived metabolites. Kinetic data showed substantially higher plasma metabolite concentrations than the brain, with slightly higher levels in NPB. The BBB transport efficiency of phenolic metabolites was validated in vitro using human brain microvascular endothelial cells (HBMECs), showing improved transport when tested as mixtures. These findings confirm that circulating phenolic metabolites from Mediterranean foods can reach brain tissues, contributing to preventing neurodegenerative diseases., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Angiogenesis as a Therapeutic Target of (Poly)phenols: Tackling Cancer and Vascular-Related Complications

  • Ávila-Gálvez, María Ángeles
  • Vico-Padilla, Antonio
  • Schneider, Claus
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
  • Giménez-Bastida, J. A.
Targeting angiogenesis as a strategy for treating cancer or vascular-associated complications is an inspiring field for many investigators. An active area within this discipline is the search for agents capable of modulating angiogenesis in order to ameliorate its structural and functional abnormalities associated with these diseases. (Poly)phenols are a broad group of molecules, many of which fall within the category of natural compounds with therapeutic potential. These potential medicinal effects have launched a considerable number of studies investigating the pro- and(or) anti-angiogenic properties of (poly)phenols in different (patho)physiological settings. The purpose of this review is to summarize the current evidence of the role of (poly)phenols in modulating angiogenesis. This review will guide the reader through preclinical and human investigations describing the pro- and anti-angiogenic effects of these compounds in different pathophysiological context, the cellular and molecular mechanisms associated, the key points in the design and evaluation of the effects described, and suggest new approaches to be considered in future studies to overcome the current limitations., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Perspective on the Coevolutionary Role of Host and Gut Microbiota in Polyphenol Health Effects: Metabotypes and Precision Health

  • Espín de Gea, Juan Carlos
  • Jarrín-Orozco, María Paula
  • Osuna-Galisteo, Leire
  • Ávila-Gálvez, María Ángeles
  • Romo-Vaquero, María
  • Selma, María Victoria
"Personalized nutrition" aims to establish nutritional strategies to improve health outcomes for non-responders. However, it is utopian since most people share similar nutritional requirements. "Precision health," encompassing lifestyles, may be more fitting. Dietary (poly)phenols are "healthy" but non-nutritional molecules (thus, we can live without them). The gut microbiota influences (poly)phenol effects, producing metabolites with different activity than their precursors. Furthermore, producing distinctive metabolites, like urolithins, lunularin, and equol, leads to the term "polyphenol-related gut microbiota metabotypes," grouping individuals based on a genuine microbial metabolism of ellagic acid, resveratrol, and isoflavones, respectively. Additionally, (poly)phenols exert prebiotic-like effects through their antimicrobial activities, typically reducing microbial diversity and modulating microbiota functionality by impacting its composition and transcriptomics. Since the gut microbiota perceives (poly)phenols as a threat, (poly)phenol effects are mostly a consequence of microbiota adaptation through differential (poly)phenol metabolism (e.g., distinctive reductions, dehydroxylations, etc.). This viewpoint is less prosaic than considering (poly)phenols as essential nutritional players in human health, yet underscores their health significance in a coevolutionary partnership with the gut microbiota. In the perspective on the gut microbiota and (poly)phenols interplay, microbiota metabotypes could arbiter health effects. An innovative aspect is also emphasized: modulating the interacting microbial networks without altering the composition., This work has been funded by the Projects PID2022-136419OB-100 (MICIU/AEI/10.13039/501100011033, Spain, and FEDER, EU) and the AGROALNEXT program (MICIU, PRTR-C17.I1, Spain) with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial

  • Jarrín-Orozco, María Paula
  • Romo Vaquero, María
  • Carrascosa, Concepción
  • Pertegal, Miriam
  • Berná, José
  • Puigcerver, Julio
  • Saura-Sanmartin, Adrián
  • Espinosa-Salinas, Isabel
  • García-Nicolás, María
  • Ávila-Gálvez, María Ángeles
  • Espín de Gea, Juan Carlos
This article belongs to the Special Issue Precision Nutrition: A Personalised Approach to Health and Age Management., [Background/Objectives:] Interindividual variability in polyphenol metabolism may help explain the inconsistent effects of polyphenol intake on health outcomes. This study compared, for the first time, (i) polyphenol-related gut microbiota metabotypes (urolithins: UM0, UMA, UMB; equol: EP, ENP; lunularin: LP, LNP) and their clusters (MCs) in non-medicated premenopausal (Pre-M) and postmenopausal (Post-M) women and (ii) the impact of an 8-week intake of a polyphenol-rich plant extract mixture (PPs) on the quality of life (QoL) of Post-M., [Methods:] Polyphenol metabotypes were determined in urine via UPLC-QTOF-MS after a 3-day intake of PPs containing resveratrol, pomegranate (ellagitannins and ellagic acid), and red clover (isoflavones) in Pre-M (n = 120) and Post-M (n = 90) women. QoL was assessed with the short-form Cervantes Scale in a randomized, placebo-controlled crossover trial (8-week PPs vs. placebo), completed by 78 Post-M participants., [Results:] At baseline, Pre-M and Post-M women showed only minor differences in metabotype and MC distributions linked to menopausal status. MC3 (UMA+EP+LP) predominated in Pre-M, while MC7 (UMA+EP+LNP) was most frequent in Post-M. PPs intake in Post-M women led to modest shifts in metabotype and MC distributions toward Pre-M patterns. Quantitative metabolite production was comparable between groups, except for equol, which showed a median 2.8-fold increase after PPs intake in EP Post-M women. Clinically meaningful improvements (score reduction ≥ 6.7 points) in QoL were observed in the Psychic domain in EP women (28%, p = 0.039) and in the Menopause and Health domain, specifically in EP (24.1%, p = 0.004), MC3 (22.5%, p = 0.043), and MC4 (UMB+EP+LP; 41.3%, p = 0.022), were mainly driven by a reduction in hot flashes (p = 0.001)., [Conclusions:] These findings support metabotyping as a tool to guide targeted dietary strategies and enhance QoL through precision health in Post-M women., This work has been funded by the Projects PID2022-136419OB-100 (Ministerio de Ciencia, Innovación y Universidades, MICIU, AEI/10.13039/501100011033, Spain) with co-funding from the EU “ERDF A way of making Europe”, ii) the AGROALNEXT program (PRTR-C17.I1, MICIU, Spain) with co-funding from the NextGenerationEU and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain). M.G.-N. acknowledges a Juan de la Cierva Postdoctoral Contract (JDC2023-051288-I) funded by MCIU/AEI/10.13039/501100011033 and the FSE+., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Urolithins and their phase II conjugates cross the blood-brain barrier and exert a stimulus-dependent anti-inflammatory effect on microglial cells by inhibiting NF-κB nuclear translocation

  • Garay-Mayol, Beatriz
  • Giménez-Bastida, J. A.
  • López-Cánovas, Diego José
  • Poveda-Lora, Sabrina
  • Navarro-Orcajada, Silvia
  • Brito, María Alexandra
  • Nunes Dos Santos, Claudia
  • Espín de Gea, Juan Carlos
  • Ávila-Gálvez, María Ángeles
  • González-Sarrías, Antonio
Neuroinflammation plays a central role in ageing and the progression of neurodegenerative diseases. Epidemiological studies suggest that consuming ellagitannins (ETs)- and ellagic acid (EA)-rich foods like pomegranate or walnuts may confer neuroprotective benefits. However, ETs and EA have low bioavailability and are extensively metabolized by the human gut microbiota into urolithins (Uros), which circulate mainly as glucuronide and sulphate conjugates. This study evaluated the ability of the main colonic Uros (Uro-A, Uro-B, and IsoUro-A), and their respective phase II conjugates, to cross human brain microvascular endothelial cells (HBMECs) as an in vitro model of the blood-brain barrier (BBB), and assessed their anti-(neuro)inflammatory effects on the BBB endothelium and human microglial cells (HMC3) under different inflammatory stimuli. UPLC-qTOF-MS analyses revealed that all Uros and their conjugates crossed the BBB, with Uro-B and its sulphate showing the highest transport efficiency. Moreover, Uros preserved BBB integrity against TNFα-induced damage. In HMC3 cells, all Uros significantly reduced IL-6 secretion, whereas only the free forms decreased IL-8 levels under LPS stimulation. However, no effects were observed in TNFα-stimulated cells, indicating a stimulus-dependent response. Additionally, all Uros prevented NF-κB nuclear translocation in LPS-treated cells, and Uro-A specifically interfered with the canonical MyD88-dependent arm of TLR4 signalling, without broadly inhibiting receptor expression or affecting the TRIF-dependent branch. These findings suggest that consuming ETs and EA-rich foods as precursors of Uros could exert anti-neuroinflammatory activity, potentially preventing or delaying the development of neurodegenerative diseases, This work was supported by the grant 22030/PI/22 funded by the Programa Regional de Fomento de la Investigación Científica y Técnica (Plan de Actuación 2022) de la Fundación Séneca-Agencia de Ciencia y Tecnología de la Región de Murcia (Murcia, Spain), the Interprofessional Lemon and Grapefruit Association (AILIMPO) (Murcia, Spain), the grant CNS2022-135253 funded by MICIU/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”, the grants PID2022-136915NA-I00 and PID2022-136419OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe”, and the AGROALNEXT program (MICIU, PRTR-C17.I1, Spain) with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain), and the grant UID 04138 funded by Instituto de Investigação do Medicamento from Portuguese Foundation for Science and Technology (FCT), Portugal. B. G-M. was funded by the grant 22777/FPI/24 (Fundación Séneca, Murcia, Spain), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Buckwheat Flavonoids Modulate Inflammation in RAW 264.7 Macrophages at Physiologically Relevant Concentrations via the LPS/COX-2 Pathway

  • López-Cánovas, Diego José
  • Vico-Padilla, Antonio
  • Zielinska, Danuta
  • Poveda-Lora, Sabrina
  • Navarro-Orcajada, Silvia
  • López-Martínez, David
  • García-Moreno, Diana
  • Ávila-Gálvez, María Ángeles
  • Garay-Mayol, Beatriz
  • Yuste, Jose E.
  • Vallejo, Fernando
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
  • Zielinski, Henryk
  • Giménez-Bastida, J. A.
Buckwheat (BW) is recognized as a functional food with antioxidant and anti-inflammatory properties. BW (poly)phenols are important bioactive compounds associated with these benefits, although their therapeutic role remains elusive. We used a multidisciplinary approach to identify the bioactive flavonoids of BW and their molecular mechanisms. Physiologically relevant concentrations of luteolin (Lute), quercetin (Quer), apigenin (Api), and kaempferol (Kaem) were effective in reducing prostaglandin (PG)E2 and PGD2 biosynthesis in LPS-activated macrophages by acting at distinct branch points of the LPS/COX-2 pathway. Lute, Api, and Kaem reduced COX-2 levels, whereas Quer exerted the opposite effect. Lute and Kaem inhibited Ikkβ phosphorylation, while TLR4 was identified as a flavonoid's target. PGE2 and PGD2 reductions were independent of COX-2 modulation and correlated with hematopoietic prostaglandin D synthase (hPGDS) inhibition (exerted by Lute and Quer). These findings offer a new perspective on the LPS/COX-2 pathway as a target of BW-derived products to address inflammation-related diseases., This project was supported by the Ramón y Cajal grant (RyC2021-032111-I) and the CNS2022-135253 grant funded by the MICIU/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” program. It was also supported by the grants PID2022-136915NA-I00 and PID2022-136419OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/UE”, the grant 202570E105 (CSIC, Spain), and the Interprofessional Lemon and Grapefruit Association (AILIMPO) (Murcia, Spain). It was also funded by the grant 22030/PI/22 funded by the Programa Regional de Fomento de la Investigación Cientı́fica y Técnica (Plan de Actuación 2022) and by the grant 23023/GERM/25 funded by the program Ayudas a los Grupos y Unidades de Excelencia Cientı́fica de la Región de Murcia de la Fundación Séneca-Agencia de Ciencia y Tecnologı́a de la Región de Murcia (Spain). It was also funded by research funds from the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences and the University of Warmia Mazury and CSIC (2025ICT020). Diana Garcı́a-Moreno was supported by the Institute of Health Carlos III through the Miguel Servet program (CP21/00028) cofunded by the European Union. David López-Martı́nez was supported by the grant for Requalification in the Spanish University System from the 2021–2023 period Margarita Salas (137/MSJD/22), funded by the “European Union NextGenerationEU/PRTR” program. Beatriz Garay-Mayol was supported by the fellowship 22777/FPI/24 funded by Fundación Séneca (Región de Murcia). Antonio Vico-Padilla was supported by the grant PREP2022-000378 funded by MICIU/AEI/10.13039/501100011033 and by ESF+. Sabrina Poveda-Lora was supported by a CSIC-funded JAE-intro fellowship (JAEINT_24_02070)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interplay between (poly)phenols, gut microbiota, and biological rhythms: outlook for a new paradigm in brain health

  • Torres-Fuentes, Cristina
  • Schellekens, Harriët
  • Cryan, John F.
  • Espín de Gea, Juan Carlos
  • Muguerza, Begoña
Dietary (poly)phenols, bioactive compounds abundantly found in plant-based foods, undergo extensive metabolism by the host and its gut microbiota, producing metabolites that influence systemic and brain health. Despite their low bioavailability, (poly)phenols have been consistently associated with neuroprotective benefits, such as reducing neuroinflammation and enhancing gut-brain communication. Additionally, circadian rhythms can influence (poly)phenol bioactivity, while these compounds, in turn, modulate biological rhythms. The gut microbiota's diurnal oscillations affect (poly)phenol metabolism and modulate (poly)phenols' effects by producing bioactive metabolites, adding complexity to their health impact. Understanding these mechanisms can aid in designing functional foods and precision nutrition strategies to enhance neuroprotection. However, critical questions remain unanswered. This review explores the interplay between (poly)phenols, circadian rhythms, and gut microbiota, highlighting their collective role in brain health. The influence of individual gut microbiota profiles, polyphenol-related metabotypes, and circadian synchrony on (poly)phenol metabolism and neuroprotection is not fully understood. Likewise, the timing of (poly)phenol consumption and its interaction with rhythmic microbial processes require further exploration. Addressing these gaps could lead to targeted dietary interventions. Future research should prioritize human trials and multi-omics approaches to unravel these complex relationships, advancing precision health strategies that foster cognitive resilience and reduce neurodegenerative disease risk., This work has been funded by the Projects i) PID2020-113739RB-I00 and PID2022-136419OB-100 (Ministerio de Ciencia, Innovación y Universidades, MICIU, AEI/10.13039/501100011033, Spain) with co-funding from the EU “ERDF A way of making Europe”, ii) the AGROALNEXT programme [PRTR-C17.I1, MICIU, Spain] with co-funding from the NextGenerationEU and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain), and iii) SFI/12/RC/2273_P2 (Science Foundation Ireland). B.M. also thanks MICIU for the support received in the framework of the mobility programs “Salvador de Madariaga” [PRX21/00592] and “Grants for the Requalification of the Spanish University System” [2021URV-RQ-01], Peer reviewed